BENZOYL PEROXIDE "OTC FEEDBACK" MEETING REQUESTED BY NDMA
This article was originally published in The Tan Sheet
Executive Summary
BENZOYL PEROXIDE "OTC FEEDBACK" MEETING REQUESTED BY NDMA to discuss the issue of potential warning labels for benzoyl peroxide-containing products. In a Dec. 21, 1993 letter to the agency, the Nonprescription Drug Manufacturers Association asked for a feedback meeting in January "given the importance of this subject across OTC categories and the timeframe of the regulatory agenda on benzoyl peroxide." A feedback session has not yet been scheduled, NDMA said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning